• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酮体在心血管疾病中对心肌灌注的调节作用:代谢和血管舒张效应

Ketone Bodies in the Regulation of Myocardial Perfusion in Cardiovascular Disease: Metabolic and Vasodilatory Effects.

作者信息

Aromiwura Afolasayo A, Gouwens Kara R, Nguyen Daniel C, Sztukowska Maryta, Didelot Luanne, Kalra Dinesh K

机构信息

Division of Cardiology, Department of Medicine, University of Louisville, Louisville, KY 40202, USA.

Department of Medicine, Christina Lee Brown Envirome Institute, Center for Cardiometabolic Science, University of Louisville, Louisville, KY 40202, USA.

出版信息

Int J Mol Sci. 2025 May 19;26(10):4856. doi: 10.3390/ijms26104856.

DOI:10.3390/ijms26104856
PMID:40429996
Abstract

Ketone bodies (KBs) serve as an alternative energy source for healthy and failing hearts and have important effects on myocardial blood perfusion in both physiological and pathological states. Early animal studies suggest that KBs may provide protective benefits in ischemic heart disease and heart failure. Under normal circumstances, coronary blood flow regulation is an intricate system with contributions from metabolic, autonomic, compressive, and endothelial factors, with the metabolic regulatory pathway being the most significant contributor. We conducted a non-systematic review of studies published between 1987 and 2024. In this review, we explored the physiological autoregulation of normal coronary blood flow, the role of ketone bodies in myocardial perfusion in health and disease, and the potential role of exogenous ketone body supplementation in producing salutary effects on myocardial blood flow (MBF) and metabolism in exercise and cardiac disease states including ischemia, heart failure, and the aging heart. Overall, our findings demonstrated that KBs improve MBF and ejection fraction in healthy human subjects and have beneficial effects on cardiac output and left heart filling pressures in patients with decompensated heart failure. Although resting myocardial blood flow decreases with age, further studies are required to assess the impact of KBs on MBF in aging populations. Additionally, more research is needed to investigate the effects of KBs during exercise and in instances of myocardial ischemia.

摘要

酮体(KBs)是健康心脏和衰竭心脏的替代能源,在生理和病理状态下对心肌血流均有重要影响。早期动物研究表明,酮体可能对缺血性心脏病和心力衰竭具有保护作用。在正常情况下,冠状动脉血流调节是一个复杂的系统,涉及代谢、自主神经、压迫和内皮等多种因素,其中代谢调节途径是最重要的因素。我们对1987年至2024年发表的研究进行了非系统性综述。在本综述中,我们探讨了正常冠状动脉血流的生理自动调节、酮体在健康和疾病状态下心肌灌注中的作用,以及外源性补充酮体对运动和包括缺血、心力衰竭及老年心脏等心脏疾病状态下心肌血流(MBF)和代谢产生有益影响的潜在作用。总体而言,我们的研究结果表明,酮体可改善健康人体受试者的心肌血流和射血分数,并对失代偿性心力衰竭患者的心输出量和左心充盈压产生有益影响。尽管静息心肌血流会随着年龄增长而减少,但仍需要进一步研究来评估酮体对老年人群心肌血流的影响。此外,还需要更多研究来探究酮体在运动期间和心肌缺血情况下的作用。

相似文献

1
Ketone Bodies in the Regulation of Myocardial Perfusion in Cardiovascular Disease: Metabolic and Vasodilatory Effects.酮体在心血管疾病中对心肌灌注的调节作用:代谢和血管舒张效应
Int J Mol Sci. 2025 May 19;26(10):4856. doi: 10.3390/ijms26104856.
2
Coenzyme Q10 for heart failure.辅酶 Q10 治疗心力衰竭。
Cochrane Database Syst Rev. 2021 Feb 3;(2)(2):CD008684. doi: 10.1002/14651858.CD008684.pub3.
3
Therapeutic Ketosis for Heart Failure: A State-of-the-Art Review.心力衰竭的治疗性酮症:最新综述
J Card Fail. 2025 Jul;31(7):1051-1061. doi: 10.1016/j.cardfail.2025.01.028. Epub 2025 Mar 3.
4
Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases.用于心血管疾病一级和二级预防的饮食预防高血压(DASH)方案。
Cochrane Database Syst Rev. 2025 May 6;5(5):CD013729. doi: 10.1002/14651858.CD013729.pub2.
5
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
6
Ketone Bodies in Cardiovascular Disease: The Vasculature as a Therapeutic Target.心血管疾病中的酮体:以血管系统作为治疗靶点
JACC Basic Transl Sci. 2025 Jul 17;10(8):101328. doi: 10.1016/j.jacbts.2025.101328.
7
Patient education in the management of coronary heart disease.冠心病管理中的患者教育
Cochrane Database Syst Rev. 2017 Jun 28;6(6):CD008895. doi: 10.1002/14651858.CD008895.pub3.
8
Beta-blockers in patients without heart failure after myocardial infarction.心肌梗死后无心力衰竭的患者使用β受体阻滞剂。
Cochrane Database Syst Rev. 2021 Nov 5;11(11):CD012565. doi: 10.1002/14651858.CD012565.pub2.
9
Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease.手机短信用于心血管疾病二级预防中的药物依从性。
Cochrane Database Syst Rev. 2024 Mar 27;3(3):CD011851. doi: 10.1002/14651858.CD011851.pub3.
10
Ventilator Management呼吸机管理

本文引用的文献

1
Myocardial Hyperemia via Cardiomyocyte Catabolism of β-Hydroxybutyrate.通过心肌细胞对β-羟基丁酸的分解代谢实现心肌充血。
Arterioscler Thromb Vasc Biol. 2025 Feb;45(2):341-343. doi: 10.1161/ATVBAHA.124.321848. Epub 2024 Dec 12.
2
Ketones and the cardiovascular system.酮体与心血管系统。
Nat Cardiovasc Res. 2023 May;2(5):425-437. doi: 10.1038/s44161-023-00259-1. Epub 2023 Apr 10.
3
Randomized Crossover Trial of 2-Week Ketone Ester Treatment in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction.
随机交叉试验:酮酯治疗 2 周对射血分数保留的 2 型糖尿病合并心力衰竭患者的影响
Circulation. 2024 Nov 12;150(20):1570-1583. doi: 10.1161/CIRCULATIONAHA.124.069732. Epub 2024 Aug 20.
4
Unraveling the Gordian knot of coronary pressure-flow autoregulation.解开冠状动脉压力-血流自动调节的戈尔迪之结。
J Mol Cell Cardiol. 2024 May;190:82-91. doi: 10.1016/j.yjmcc.2024.04.008. Epub 2024 Apr 11.
5
Enantiomer-Specific Cardiovascular Effects of the Ketone Body 3-Hydroxybutyrate.手性特定的酮体 3-羟基丁酸的心血管效应。
J Am Heart Assoc. 2024 Apr 16;13(8):e033628. doi: 10.1161/JAHA.123.033628. Epub 2024 Apr 2.
6
Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction: A Randomized, Controlled, Double-Blind Trial.口服酮酯治疗射血分数降低的心力衰竭患者的心血管效应:一项随机、对照、双盲试验。
Circulation. 2024 May 7;149(19):1474-1489. doi: 10.1161/CIRCULATIONAHA.123.067971. Epub 2024 Mar 27.
7
Circulating ketone bodies and mortality in heart failure: a community cohort study.循环酮体与心力衰竭死亡率:一项社区队列研究。
Front Cardiovasc Med. 2024 Jan 24;11:1293901. doi: 10.3389/fcvm.2024.1293901. eCollection 2024.
8
Exploring the Cardiovascular Benefits of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: Expanding Horizons Beyond Diabetes Management.探索钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂的心血管益处:超越糖尿病管理拓展视野
Cureus. 2023 Sep 30;15(9):e46243. doi: 10.7759/cureus.46243. eCollection 2023 Sep.
9
Ketone body 3-hydroxybutyrate elevates cardiac output through peripheral vasorelaxation and enhanced cardiac contractility.酮体 3-羟丁酸通过外周血管舒张和增强心肌收缩力来提高心输出量。
Basic Res Cardiol. 2023 Sep 9;118(1):37. doi: 10.1007/s00395-023-01008-y.
10
Beneficial Effects of Ketone Ester in Patients With Cardiogenic Shock: A Randomized, Controlled, Double-Blind Trial.酮酯对心源性休克患者的有益作用:一项随机、对照、双盲试验。
JACC Heart Fail. 2023 Oct;11(10):1337-1347. doi: 10.1016/j.jchf.2023.05.029. Epub 2023 Jul 12.